PCRX Share Price

Open 34.75 Change Price %
High 36.15 1 Day 0.15 0.42
Low 34.35 1 Week -0.05 -0.14
Close 36.00 1 Month -12.70 -26.08
Volume 762554 1 Year -3.86 -9.68
52 Week High 58.95
52 Week Low 29.95
PCRX Important Levels
Resistance 2 37.67
Resistance 1 36.98
Pivot 35.50
Support 1 35.02
Support 2 34.33
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.03 50.00%
LOCM 0.09 50.00%
ATEA 2.50 32.98%
ATEA 2.50 32.98%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
BGMD 0.05 25.00%
ATRM 1.70 21.43%
MIND 3.33 15.62%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
DCIX 0.26 -40.91%
More..

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX)

PCRX Technical Analysis 4
As on 23rd Aug 2017 PCRX Share Price closed @ 36.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 41.02 & Strong Sell for SHORT-TERM with Stoploss of 43.33 we also expect STOCK to react on Following IMPORTANT LEVELS.
PCRX Target for August
1st Target up-side 46.01
2nd Target up-side 50.58
3rd Target up-side 55.14
1st Target down-side 32.99
2nd Target down-side 28.42
3rd Target down-side 23.86
PCRX Other Details
Segment EQ
Market Capital 512069248.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.pacira.com
PCRX Address
PCRX
5 Sylvan Way
Suite 100
Parsippany, NJ 07054
United States
Phone: 973-254-3560
PCRX Latest News
Interactive Technical Analysis Chart Pacira Pharmaceuticals, Inc. ( PCRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacira Pharmaceuticals, Inc.
PCRX Business Profile
Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome injection) is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine; and DepoDur (morphine sulfate extended-release liposome injection) is an extended-release, injectable formulation of morphine.